CAR-T Cell Therapy in Lymphomas: How Far Have We Come? John S. Gates Seminar Series
About this Event
Manali Kamdar, MD, MBBS, is an associate professor in the Department of Medicine-Hematology.
CAR-T therapy represents a cutting-edge advancement in lymphoma treatment, significantly improving outcomes for patients with both aggressive and indolent forms of the disease. However, challenges persist, and this talk will explore strategies to enhance existing constructs. It will highlight CU’s efforts in developing next-generation CARs aimed at achieving even better outcomes with reduced toxicity.
This is a hybrid event; Attendees can join us at the AHSB, Room P12-2004, or on Zoom at https://ucdenver.zoom.us/j/97718315497